These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11154121)

  • 1. Effect of sodium arachidonate on thrombin generation through platelet activation--inhibitory effect of aspirin.
    Altman R; Scazziota A; Rouvier J; Gonzalez C
    Thromb Haemost; 2000 Dec; 84(6):1109-12. PubMed ID: 11154121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation.
    Altman R; Scazziota A; DE Lourdes Herrera M; Gonzalez C
    J Thromb Haemost; 2006 Sep; 4(9):2022-7. PubMed ID: 16961610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abciximab does not inhibit the increase of thrombin generation produced in platelet-rich plasma in vitro by sodium arachidonate or tissue factor.
    Altman R; Scazziota A; Santoro S; Gonzalez C
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):271-7. PubMed ID: 16015412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of platelet reactivity in clopidogrel-treated subjects.
    Vilahur G; Choi BG; Zafar MU; Viles-Gonzalez JF; Vorchheimer DA; Fuster V; Badimon JJ
    J Thromb Haemost; 2007 Jan; 5(1):82-90. PubMed ID: 17239165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid.
    Carroll RC; Craft RM; Chavez JJ; Snider CC; Bresee SJ; Cohen E
    J Lab Clin Med; 2005 Jul; 146(1):30-5. PubMed ID: 16025089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression.
    Scazziota A; Altman R; Rouvier J; Gonzalez C; Ahmed Z; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2000 Dec; 100(6):479-88. PubMed ID: 11152927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study.
    Jayaram P; Yeh P; Patel SJ; Cela R; Shybut TB; Grol MW; Lee BH
    Am J Sports Med; 2019 Apr; 47(5):1223-1229. PubMed ID: 30888847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry.
    Hübl W; Assadian A; Lax J; Meixner U; Fang IF; Hagmüller G; Panzer S; Bayer PM
    Thromb Res; 2007; 121(1):135-43. PubMed ID: 17467777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
    Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
    Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.
    Rajagopalan S; Ford I; Bachoo P; Hillis GS; Croal B; Greaves M; Brittenden J
    J Thromb Haemost; 2007 Oct; 5(10):2028-35. PubMed ID: 17650080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.
    Santos MT; Valles J; Lago A; Tembl J; Sánchez E; Moscardo A; Cosin J
    J Thromb Haemost; 2008 Apr; 6(4):615-21. PubMed ID: 18221358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary.
    Linnemann B; Schwonberg J; Mani H; Prochnow S; Lindhoff-Last E
    J Thromb Haemost; 2008 Apr; 6(4):677-83. PubMed ID: 18182038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intramyocardial injection of platelet-rich plasma on the healing process after myocardial infarction.
    Li XH; Zhou X; Zeng S; Ye F; Yun JL; Huang TG; Li H; Li YM
    Coron Artery Dis; 2008 Aug; 19(5):363-70. PubMed ID: 18607174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
    Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
    J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.